ANI Pharmaceuticals Inc [ANIP] stock prices are up 0.64% to $60.19 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ANIP shares have gain 1.06% over the last week, with a monthly amount glided 10.24%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
ANI Pharmaceuticals Inc [NASDAQ: ANIP] stock has seen the most recent analyst activity on December 11, 2024, when Leerink Partners initiated its Outperform rating and assigned the stock a price target of $80. Previously, Piper Sandler started tracking the stock with Overweight rating on October 11, 2024, and set its price target to $68. On March 15, 2024, CapitalOne initiated with a Overweight rating and assigned a price target of $80 on the stock. H.C. Wainwright reiterated its Buy rating and increased its price target to $73 on August 22, 2023. Guggenheim initiated its recommendation with a Buy and recommended $55 as its price target on March 01, 2023. H.C. Wainwright started tracking with a Buy rating for this stock on September 07, 2022, and assigned it a price target of $50. In a note dated November 02, 2021, Truist initiated an Buy rating and provided a target price of $70 on this stock.
The stock price of ANI Pharmaceuticals Inc [ANIP] has been fluctuating between $52.50 and $70.81 over the past year. Currently, Wall Street analysts expect the stock to reach $71.5 within the next 12 months. ANI Pharmaceuticals Inc [NASDAQ: ANIP] shares were valued at $60.19 at the most recent close of the market. An investor can expect a potential return of 18.79% based on the average ANIP price forecast.
Analyzing the ANIP fundamentals
The ANI Pharmaceuticals Inc [NASDAQ:ANIP] reported sales of 555.46M for trailing twelve months, representing a surge of 12.52%. Gross Profit Margin for this corporation currently stands at 0.52% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at -0.01%, and Net Profit Margin reading is -0.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.01, Equity is -0.02 and Total Capital is 0.01. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.45.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 59.15 points at the first support level, and at 58.10 for the second support level. However, for the 1st resistance point, the stock is sitting at 61.12, and for the 2nd resistance point, it is at 62.04.
Ratios To Look Out For
It’s worth pointing out that ANI Pharmaceuticals Inc [NASDAQ:ANIP]’s Current Ratio is 2.74. Also, the Quick Ratio is 1.96, while the Cash Ratio stands at 0.76. Considering the valuation of this stock, the price to sales ratio is 2.28, the price to book ratio is 3.13.
Transactions by insiders
Recent insider trading involved Cook Meredith, SR. VP, GENERAL COUNSEL & SEC., that happened on Jan 13 ’25 when 400.0 shares were sold. SVP & CFO, CAREY STEPHEN P. completed a deal on Dec 17 ’24 to sell 7500.0 shares. Meanwhile, Officer CAREY STEPHEN P. bought 7500.0 shares on Dec 17 ’24.
